Treatment of hypercalcemias.
D000284:Administration, Oral; D002116:Calcitonin / Q000627:therapeutic use; D002136:Calcium, Dietary / Q000009:adverse effects; D002951:Citrates; D004232:Diuretics / Q000009:adverse effects; D004492:Edetic Acid / Q000627:therapeutic use; D004976:Ethacrynic Acid / Q000627:therapeutic use; D005110:Extracellular Space; D005665:Furosemide / Q000627:therapeutic use; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D006934:Hypercalcemia / Q000139:chemically induced / Q000188:drug therapy* / Q000209:etiology; D007275:Injections, Intravenous; D007552:Isotonic Solutions; D009369:Neoplasms / Q000150:complications; D010710:Phosphates / Q000627:therapeutic use; D006435:Renal Dialysis; D012964:Sodium / Q000627:therapeutic use; D013148:Spironolactone / Q000009:adverse effects; D013431:Sulfates / Q000627:therapeutic use; D014807:Vitamin D / Q000009:adverse effects
D002136:Calcium, Dietary; D002951:Citrates; D004232:Diuretics; D005938:Glucocorticoids; D007552:Isotonic Solutions; D010710:Phosphates; D013431:Sulfates; D014807:Vitamin D; D013148:Spironolactone; D005665:Furosemide; D002116:Calcitonin; D004492:Edetic Acid; D012964:Sodium; D004976:Ethacrynic Acid